Combined immunophenotyping and FISH identifies the involvement of B‐cells in 5q‐ syndrome

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1035>3.0.CO;2-LPMID 10992302
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cytogenetic delineation of the critical deleted region in the 5q− syndrome

  1998cited by this paper
• Report of the Fourth International Workshop on Human Chromosome 5 mapping 1996

  1998cited by this paper
• 5q-, twenty-five years later: a synopsis.

  1997cited by this paper
• Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells

  1997influential reference
• LINEAGE SPECIFICITY IN HAEMATOLOGICAL NEOPLASMS

  1997cited by this paper
• Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion

  1995cited by this paper
• Transformation of chronic myelomonocytic leukemia to acute lymphoblastic leukemia: Case report and review of the literature of lymphoblastic transformation of myelodysplastic syndrome

  1995cited by this paper
• Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.

  1995cited by this paper
• Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells.

  1994influential reference
• The 5q-syndrome.

  1994cited by this paper
• Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.

  1994influential reference
• Deletions of chromosome 5 in malignant myeloid disorders.

  1993cited by this paper
• Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions.

  1993cited by this paper
• Report of the second international workshop on human chromosome 5 mapping.

  1992cited by this paper
• Isolation of a candidate human hematopoietic stem-cell population.

  1992cited by this paper
• Clonal proliferation of murine lymphohemopoietic progenitors in culture.

  1992cited by this paper
• Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.

  1992influential reference
• Bipotential precursors of B cells and macrophages in murine fetal liver

  1992cited by this paper
• Deletions of chromosome 5 in malignant myeloid disorders.

  1992cited by this paper
• Clonality of cell populations in refractory anaemia using combined approach of gene loss and X‐linked restriction fragment length polymorphism‐methylation analyses

  1991influential reference
• HOMOZYGOUS DELETION OF FMS IN A PATIENT WITH THE 5q— SYNDROME

  1990cited by this paper
• Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages.

  1988cited by this paper
• Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome.

  1987influential reference
• Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias.

  1987cited by this paper
• APAAP labelling of blood and bone-marrow samples for phenotyping leukaemia.

  1986cited by this paper
• Evidence for a multistep pathogenesis of a myelodysplastic syndrome.

  1984cited by this paper
• Chronic myelomonocytic leukemia with a chromosome abnormality (46,XY,20q–) in all dividing myeloid cells: Evidence for clonal origin in a multipotent stem cell common to granulocyte, monocyte, erythrocyte, and thrombocyte

  1983influential reference
• Distinct haematological disorder with deletion of long arm of No. 5 chromosome

  1974cited by this paper
• SELF-MUTILATION IN LESCH-NYHAN SYNDROME

  1974cited by this paper

• Quantitative evaluation of treatment response to lenalidomide by applying fluorescence in situ hybridization for peripheral blood granulocytes in a patient with 5q– syndrome

  2022cites this paper
• Developing Digital Photomicroscopy

  2022cites this paper
• Investigating the mechanism of bone marrow failure observed in patients with acute myeloid leukaemia

  2018cites this paper
• The utility of hematopoietic stem cell karyotyping in the diagnosis of de novo myelodysplastic syndromes

  2016cites this paper
• The myelodysplastic syndromes

  2016cites this paper
• Development of Cytogenetic Abnormalities in Myelodysplastic Syndromes

  2016cites this paper
• Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide.

  2015cites this paper
• Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization

  2014cites this paper
• Stem cell origin of myelodysplastic syndromes

  2014cites this paper
• myelodysplastic syndromes - of 5q The molecular signature of MDS stem cells supports a stem-cell origin

  2013cites this paper
• [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].

  2013cites this paper
• TP53 mutations in myelodysplastic syndromes with deletion of 5q

  2013cites this paper
• The Biology of Myelodysplastic Syndrome Associated with Isolated del(5q)

  2013cites this paper
• Groupe Français de Cytogénétique Hématologique the chromosomal changes affecting 6 major targets: a study of 21 cases by DC2 acute leukemia is characterized by recurrent clonal + , CD56 + CD4

  2012cites this paper
• Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient

  2012cites this paper
• Identification of the Genomic Breakpoints of a Novel Chromosome Translocation in Myelodysplastic Syndrome

  2011cites this paper
• Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion

  2010cites this paper
• Advances in the 5 q syndrome

  2010cites this paper
• Advances in the 5q- syndrome.

  2010cites this paper
• Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis

  2009cites this paper
• Myelodysplastic syndromes: biology and treatment

  2009cites this paper
• Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes.

  2009cites this paper
• Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes

  2008cites this paper
• Molecular Pathogenesis of the 5q– Syndrome: The Role of RPS14 in Pathogenesis and SPARC in the Hematologic Response to Lenalidomide

  2008cites this paper
• Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.

  2008cites this paper
• Studies of anemia in the myelodysplastic syndromes

  2008cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.

  2007cites this paper
• Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile.

  2007influential citation
• Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• The molecular signature of MDS stem cells supports a stem-cell origin of 5q (cid:1) myelodysplastic syndromes

  2007cites this paper
• Classification of chronic myeloid disorders: from Dameshek towards a semi-molecular system.

  2006cites this paper
• Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.

  2006cites this paper
• Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity.

  2005cites this paper
• Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the future.

  2004cites this paper
• Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the future

  2004cites this paper
• Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.

  2004cites this paper
• Primitive hematopoietic stem cells show a polyclonal pattern in myelodysplastic syndromes

  2004cites this paper
• Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.

  2004cites this paper
• Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes

  2004cites this paper
• Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

  2003cites this paper
• Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome.

  2003cites this paper
• Molecular studies in myelodysplastic syndromes

  2003cites this paper
• Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.

  2002cites this paper
• CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

  2002cites this paper
• Detection of chromosome abnormalities in leukemia using fluorescence in situ hybridization.

  2002cites this paper
• CD4 (cid:1) , CD56 (cid:1) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Franc¸ais de Cytoge´ne´tique He´matologique

  2002cites this paper
• Fluorescence in situ hybridization for the study of cell lineage involvement in myelodysplastic syndromes with chromosome 5 anomalies.

  2002cites this paper
• Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies

  2002cites this paper
• Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.

  2001cites this paper
• Molecular cytogenetics.

  2001cites this paper
• Clonality in the Myelodysplastic Syndromes

  2001cites this paper
• Myelodysplastic syndromes: recent advances.

  2001cites this paper
• Myelodysplastic Syndromes Myelodysplastic syndromes : recent advances

  2001cites this paper
• Becker Digital

  year unknowncites this paper
• Mediterranean Journal of Hematology and Infectious Diseases Recent Advances in the 5q-syndrome

  year unknowncites this paper